Mucoadhesive drug delivery systems: a promising noninvasive approach to bioavailability enhancement. Part II: formulation considerations

References

• Edsman K, Hägerström H. Pharmaceutical applications of mucoadhesion for the non-oral routes. J Pharm Pharmacol. 2005;57(1):3–22.
   PubMed Web of Science ®Google Scholar
• Jiménez-castellanos MR, Zia H, Rhodes CT. Mucoadhesive drug delivery systems. Drug Dev Ind Pharm. 1993;19(1–2):143–194.
   Web of Science ®Google Scholar
• Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev. 2005;57(11):1556–1568.
   PubMed Web of Science ®Google Scholar
• Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm. 2009;71(3):505–518.
   PubMed Web of Science ®Google Scholar
• Shaikh R, Raj Singh TR, Garland MJ, et al. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011;3(1):89–100.
   PubMed Web of Science ®Google Scholar
• Hamman JH, Enslin GM, Kotzé AF. Oral delivery of peptide drugs: barriers and developments. BioDrugs. 2005;19(3):165–177.
   PubMed Web of Science ®Google Scholar
• 2022 DMR. Global transmucosal drug delivery devices market – industry trends and forecast to 20292022 [ cited 21 December 2022] https://www.databridgemarketresearch.com/reports/global-transmucosal-drug-delivery-devices-market
   Google Scholar
• Zizzari AT, Pliatsika D, Gall FM, et al. New perspectives in oral peptide delivery. Drug Discov Today. 2021;26(4):1097–1105.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Chen Z, Paul PK, et al. Oral delivery of proteins and peptides: challenges, status quo and future perspectives. Acta Pharm Sin B. 2021;11(8):2416–2448.
   PubMed Web of Science ®Google Scholar
• Scrivener CA, Schantz CW. Penicillin; new methods for its use in dentistry. J Am Dent Assoc. 1947;35(9):644–647.
   PubMed Web of Science ®Google Scholar
• Gurny R, Meyer JM, Peppas NA. Bioadhesive intraoral release systems: design, testing and analysis. Biomaterials. 1984;5(6):336–340.
   PubMed Web of Science ®Google Scholar
• Peppas NA, Buri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release. 1985;2:257–275.
   Google Scholar
• Smart JD, Kellaway IW, Worthington HE. An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J Pharm Pharmacol. 1984;36(5):295–299.
   PubMed Web of Science ®Google Scholar
• Saettone MF, Chetoni P, Tilde Torracca M, et al. Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid. Int J Pharm. 1989;51(3):203–212.
   Google Scholar
• Harris D, Robinson JR. Bioadhesive polymers in peptide drug delivery. Biomaterials. 1990;11(9):652–658.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Niwa T, et al. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res. 1996;13(6):896–901.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev. 2001;47(1):39–54.
   PubMed Web of Science ®Google Scholar
• Bonengel S, Bernkop-Schnürch A. Thiomers–from bench to market. J Control Release. 2014;195:120–129.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Greimel A. Thiomers. Am J Drug Del. 2005;3(3):141–154.
   Google Scholar
• Liu H, Cai Z, Wang F, et al. Colon-targeted adhesive hydrogel microsphere for regulation of gut immunity and flora. Adv Sci. 2021;8(18):2101619.
   Web of Science ®Google Scholar
• Kilicarslan M, Ilhan M, Inal O, et al. Preparation and evaluation of clindamycin phosphate loaded chitosan/alginate polyelectrolyte complex film as mucoadhesive drug delivery system for periodontal therapy. Eur J Pharm Sci. 2018;123:441–451.
   PubMed Web of Science ®Google Scholar
• Wang B, Zhang K, Wang J, et al. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy. Colloids Surf B Biointerfaces. 2020;189:110832.
   PubMed Web of Science ®Google Scholar
• Rothner JT, Cobe HM, et al. An adhesive penicillin ointment for topical application. J Dent Res. 1949;28(6):544–548.
   PubMed Web of Science ®Google Scholar
• Goldstein PJ, Lipman M, Luebehusen J. A controlled clinical trial of two local agents in postepisiotomy pain and discomfort. South Med J. 1977;70(7):806–808.
   PubMed Web of Science ®Google Scholar
• Ishida M, Nambu N, Nagai T. Highly viscous gel ointment containing carbopol for application to the oral mucosa. Chem Pharm Bull (Tokyo). 1983;31(12):4561–4564.
   PubMed Web of Science ®Google Scholar
• Longer MA, Ch’Ng HS, Robinson JR. Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer. J Pharm Sci. 1985;74(4):406–411.
   PubMed Web of Science ®Google Scholar
• Illum L, Jørgensen H, Bisgaard H, et al. Bioadhesive microspheres as a potential nasal drug delivery system. Int J Pharm. 1987;39(3):189–199.
   Google Scholar
• Boddé HE, De Vries ME, Junginger HE. Mucoadhesive polymers for the buccal delivery of peptides, structure-adhesiveness relationships. J Control Release. 1990;13(2):225–231.
   Web of Science ®Google Scholar
• Lee C-H, Chien YW. Development and evaluation of a mucoadhesive drug delivery system for dual-controlled delivery of nonoxynol-9. J Control Release. 1996;39(1):93–103.
   Web of Science ®Google Scholar
• Eiamtrakarn S, Itoh Y, Kishimoto J, et al. Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein. Biomaterials. 2002;23(1):145–152.
   PubMed Web of Science ®Google Scholar
• Nepp J, Knoetzl W, Prinz A, et al. Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera®) eye drops: a retrospective case series. Int Ophthalmol. 2020;40(6):1547–1552.
   PubMed Web of Science ®Google Scholar
• Yan Y, Sun Y, Wang P, et al. Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis. Carbohydr Polym. 2020;246:116660.
   PubMed Web of Science ®Google Scholar
• Park H, Robinson JR. Physico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion. J Control Release. 1985;2:47–57.
   Google Scholar
• Mol O, Oudega B. Molecular and structural aspects of fimbriae biosynthesis and assembly in Escherichia coli. FEMS Microbiol Rev. 1996;19(1):25–52.
   PubMed Web of Science ®Google Scholar
• Haas J, Lehr CM. Developments in the area of bioadhesive drug delivery systems. Expert Opin Biol Ther. 2002;2(3):287–298.
   PubMed Web of Science ®Google Scholar
• Woodley J. Bioadhesion: new possibilities for drug administration? Clin Pharmacokinet. 2001;40(2):77–84.
   PubMed Web of Science ®Google Scholar
• Singh I, Pawar P, Sanusi EA, et al. Mucoadhesive polymers for drug delivery systems. Adhesion in Pharmaceutical, Biomedical and Dental Fields 2017. p. 89–113.
   Google Scholar
• Bayer IS. Recent advances in mucoadhesive interface materials, mucoadhesion characterization, and technologies. Adv Mater Interfaces. 2022;9(18):2200211.
   Web of Science ®Google Scholar
• Laffleur F. Mucoadhesive therapeutic compositions: a patent review (2011–2014). Expert Opin Ther Pat. 2016;26(3):377–388.
   PubMed Web of Science ®Google Scholar
• Chen G, Kang W, Li W, et al. Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies. Theranostics. 2022;12(3):1419–1439.
   PubMed Web of Science ®Google Scholar
• Ijaz M, Bernkop-Schnürch A. Preactivated thiomers: their role in drug delivery. Expert Opin Drug Deliv. 2015;12(8):1269–1281.
   PubMed Web of Science ®Google Scholar
• Laffleur F, Bernkop-Schnürch A. Thiomers: promising platform for macromolecular drug delivery. Future Med Chem. 2012;4(17):2205–2216.
   PubMed Web of Science ®Google Scholar
• Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: the next generation. J Pharm Sci. 2000;89(7):850–866.
   PubMed Web of Science ®Google Scholar
• Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2012;37(1):106–126.
   PubMed Web of Science ®Google Scholar
• Wagh MP, Joshi O, Patel JS, et al. Thiomers: a new generation of mucoadhesive polymers. Res J Pharm Technol. 2009;2:250–255.
   Google Scholar
• Oguri S, Amano K, Nakashita H, et al. Molecular structure and properties of lectin from tomato fruit. Biosci Biotechnol Biochem. 2008;72(10):2640–2650.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhai Y, Zhang N, et al. The development of polycarbophil as a bioadhesive material in pharmacy. Asian J Pharm Sci. 2013;8(4):218–227.
   Google Scholar
• Watchorn J, Stuart S, Burns DC, et al. Mechanistic influence of polymer species, molecular weight, and functionalization on mucin–polymer binding interactions. ACS Appl Polym Mater. 2022;4(10):7537–7546.
   Web of Science ®Google Scholar
• Blanco-Fuente H, Anguiano-Igea S, Otero-Espinar FJ, et al. In-vitro bioadhesion of carbopol hydrogels. Int J Pharm. 1996;142(2):169–174.
   Web of Science ®Google Scholar
• Roy S, Pal K, Anis A, et al. Polymers in mucoadhesive drug-delivery systems: a brief note. Des Monomers Polym. 2009;12(6):483–495.
   Web of Science ®Google Scholar
• Grabovac V, Guggi D, Bernkop-Schnürch A. Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev. 2005;57(11):1713–1723.
   PubMed Web of Science ®Google Scholar
• Zhang L, Qin H, Li J, et al. Preparation and characterization of layer-by-layer hypoglycemic nanoparticles with pH-sensitivity for oral insulin delivery [10.1039/C8TB02113A]. J Mat Chem B. 2018;6(45):7451–7461.
   PubMed Web of Science ®Google Scholar
• Kutscher AH, Zegarelli EV. Use of a new adhesive powder vehicle (orahesive) for the application of drugs to lesions of the mouth. Arch Dermatol. 1961;84:1033–1035.
   PubMedGoogle Scholar
• Roy SK, Prabhakar B. Bioadhesive polymeric platforms for transmucosal drug delivery systems – a review. Trop J Pharm Res. 2010;9:91–104.
   Web of Science ®Google Scholar
• Nagai T. Adhesive topical drug delivery system. J Control Release. 1985;2:121–134.
   Google Scholar
• Mayer KH, Peipert J, Fleming T, et al. Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. Clin Infect Dis. 2001;32(3):476–482.
   PubMed Web of Science ®Google Scholar
• Mishra B, Singh J Novel drug delivery systems and significance in respiratory diseases. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Australia: Elsevier; 2020. p. 57–95.
   Google Scholar
• Weers J, Tarara T. The pulmosphere™ platform for pulmonary drug delivery. Ther Deliv. 2014;5(3):277–295.
   PubMedGoogle Scholar
• Rosière R, Van Woensel M, Gelbcke M, et al. New folate-grafted chitosan derivative to improve delivery of paclitaxel-loaded solid lipid nanoparticles for lung tumor therapy by inhalation. Mol Pharm. 2018;15(3):899–910.
   PubMed Web of Science ®Google Scholar
• Khare A, Grover K, Pawar P, et al. Mucoadhesive Polymers for Enhancing Retention in Ocular Drug Delivery. In: Mittal, K, editors. Progress in Adhesion and Adhesives. United States: Scrivener Publishing LLC; 2015. p. 451–484.
   Google Scholar
• Agibayeva LE, Kaldybekov DB, Porfiryeva NN, et al. Gellan gum and its methacrylated derivatives as in situ gelling mucoadhesive formulations of pilocarpine: in vitro and in vivo studies. Int J Pharm. 2020;577:119093.
   PubMedGoogle Scholar
• Dubey SK, Parab S, Dabholkar N, et al. Oral peptide delivery: challenges and the way ahead. Drug Discov Today. 2021;26(4):931–950.
   PubMed Web of Science ®Google Scholar
• Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech. 2015;16(4):731–741.
   PubMed Web of Science ®Google Scholar
• Chaubey P, Momin M, Sawarkar S. Significance of ligand-anchored polymers for drug targeting in the treatment of colonic disorders [review]. Front Pharmacol. 2020;10:1628.
   PubMed Web of Science ®Google Scholar
• Golshani S, Vatanara A, Amin M. Recent advances in oral mucoadhesive drug delivery. J Pharm Pharm Sci. 2022;25:201–217.
   PubMed Web of Science ®Google Scholar
• Karn PR, Vanić Z, Pepić I, et al. Mucoadhesive liposomal delivery systems: the choice of coating material. Drug Dev Ind Pharm. 2011;37(4):482–488.
   PubMed Web of Science ®Google Scholar
• Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64(6):557–570.
   PubMed Web of Science ®Google Scholar
• Shrestha N, Shahbazi M-A, Araújo F, et al. Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: a controlled dual protein-drug delivery system. Biomaterials. 2015;68:9–20.
   PubMed Web of Science ®Google Scholar
• Shan W, Zhu X, Liu M, et al. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. ACS Nano. 2015;9(3):2345–2356.
   PubMed Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99(Pt A):28–51.
   PubMed Web of Science ®Google Scholar
• Varum FJ, Veiga F, Sousa JS, et al. Mucoadhesive platforms for targeted delivery to the colon. Int J Pharm. 2011;420(1):11–19.
   PubMedGoogle Scholar
• Banerjee A, Lee J, Mitragotri S. Intestinal mucoadhesive devices for oral delivery of insulin. Bioeng Transl Med. 2016;1(3):338–346.
   PubMed Web of Science ®Google Scholar
• Lee SH, Bajracharya R, Min JY, et al. Strategic approaches for colon targeted drug delivery: an overview of recent advancements. Pharmaceutics. 2020;12:1.
   Web of Science ®Google Scholar
• Schellekens RC, Baltink JH, Woesthuis EM, et al. Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics. Pharm Dev Technol. 2012;17(1):40–47.
   PubMed Web of Science ®Google Scholar
• Varum F, Freire AC, Fadda HM, et al. A dual pH and microbiota-triggered coating (Phloral™) for fail-safe colonic drug release. Int J Pharm. 2020;583:119379.
   PubMedGoogle Scholar
• Bustamante-Marin XM, Ostrowski LE. Cilia and mucociliary clearance. Cold Spring Harb Perspect Biol. 2017;9:4.
   Web of Science ®Google Scholar
• de Souza Carvalho C, Daum N, Lehr CM. Carrier interactions with the biological barriers of the lung: advanced in vitro models and challenges for pulmonary drug delivery. Adv Drug Deliv Rev. 2014;75:129–140.
   PubMed Web of Science ®Google Scholar
• Amore E, Ferraro M, Manca ML, et al. Mucoadhesive solid lipid microparticles for controlled release of a corticosteroid in the chronic obstructive pulmonary disease treatment. Nanomedicine (Lond). 2017;12(19):2287–2302.
   PubMed Web of Science ®Google Scholar
• Sakagami M, Sakon K, Kinoshita W, et al. Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres. J Control Release. 2001;77(1–2):117–129.
   PubMed Web of Science ®Google Scholar
• Surendrakumar K, Martyn GP, Hodgers EC, et al. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J Control Release. 2003;91(3):385–394.
   PubMed Web of Science ®Google Scholar
• Paul P, Sengupta S, Mukherjee B, et al. Chitosan-coated nanoparticles enhanced lung pharmacokinetic profile of voriconazole upon pulmonary delivery in mice. Nanomedicine (Lond). 2018;13(5):501–520.
   PubMed Web of Science ®Google Scholar
• Wadhwa R, Bharathala S, Aggarwal T, et al. Pulmonary Bioadhesive Drug Delivery Systems and their Applications. In: Mittal, K, Bakshi, I, Narang, J, editors. Bioadhes Drug Deliv. United States: Scrivener Publishing LLC; 2020. p. 371–390.
   Google Scholar
• Yang TT, Wen BF, Liu K, et al. Cyclosporine A/porous quaternized chitosan microspheres as a novel pulmonary drug delivery system. Artif Cells Nanomed Biotechnol. 2018;46(sup2):552–564.
   PubMed Web of Science ®Google Scholar
• Schuster BS, Suk JS, Woodworth GF, et al. Nanoparticle diffusion in respiratory mucus from humans without lung disease. Biomaterials. 2013;34(13):3439–3446.
   PubMed Web of Science ®Google Scholar
• Lynch C, Kondiah PPD, Choonara YE, et al. Advances in biodegradable nano-sized polymer-based ocular drug delivery. Polymers (Basel). 2019;11:8.
   Web of Science ®Google Scholar
• Yu A, Shi H, Liu H, et al. Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery. Int J Pharm. 2020;575:118943.
   PubMedGoogle Scholar
• Bhatta RS, Chandasana H, Chhonker YS, et al. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies. Int J Pharm. 2012;432(1–2):105–112.
   PubMedGoogle Scholar
• Xu W, Liu K, Li T, et al. An in situ hydrogel based on carboxymethyl chitosan and sodium alginate dialdehyde for corneal wound healing after alkali burn. J Biomed Mater Res A. 2019;107(4):742–754.
   PubMed Web of Science ®Google Scholar
• Delrish E, Jabbarvand M, Ghassemi F, et al. Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma. Exp Eye Res. 2021;204:108423.
   PubMed Web of Science ®Google Scholar
• Naik JB, Pardeshi SR, Patil RP, et al. Mucoadhesive micro-/nano carriers in ophthalmic drug delivery: an overview. BioNanoScience. 2020;10(3):564–582.
   Web of Science ®Google Scholar
• Cook MT, Brown MB. Polymeric gels for intravaginal drug delivery. J Control Release. 2018;270:145–157.
   PubMed Web of Science ®Google Scholar
• Vermani K, Garg S. The scope and potential of vaginal drug delivery. Pharm Sci Technol Today. 2000;3(10):359–364.
   PubMedGoogle Scholar
• Hassan AS, Soliman GM, Ali MF, et al. Mucoadhesive tablets for the vaginal delivery of progesterone: in vitro evaluation and pharmacokinetics/pharmacodynamics in female rabbits. Drug Dev Ind Pharm. 2018;44(2):224–232.
   PubMed Web of Science ®Google Scholar
• Chaturvedi M, Kumar M, Pathak K. A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Technol Res. 2011;2(4):215–222.
   PubMedGoogle Scholar
• Alexander A, Agrawal M, Uddin A, et al. Recent expansions of novel strategies towards the drug targeting into the brain. Int J Nanomedicine. 2019;14:5895–5909.
   PubMed Web of Science ®Google Scholar
• Alshweiat A, Csóka I, Tömösi F, et al. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: preparation, characterization, and in vivo evaluation. Int J Pharm. 2020;579:119166.
   PubMedGoogle Scholar
• Ugwoke MI, Agu RU, Verbeke N, et al. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev. 2005;57(11):1640–1665.
   PubMed Web of Science ®Google Scholar
• Pavis H, Wilcock A, Edgecombe J, et al. Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer. J Pain Symptom Manage. 2002;24(6):598–602.
   PubMed Web of Science ®Google Scholar
• Bastos F, Pinto AC, Nunes A, et al. Oromucosal products - Market landscape and innovative technologies: a review. J Control Release. 2022;348:305–320.
   PubMed Web of Science ®Google Scholar
• Paris A-L, Caridade S, Colomb E, et al. Sublingual protein delivery by a mucoadhesive patch made of natural polymers. Acta Biomater. 2021;128:222–235.
   PubMed Web of Science ®Google Scholar
• Ashri LY, Abou El Ela AESF, Ibrahim MA, et al. Optimization and evaluation of chitosan buccal films containing tenoxicam for treating chronic periodontitis: in vitro and in vivo studies. J Drug Delivery Sci Technol. 2020;57:101720.
   Web of Science ®Google Scholar
• Morales JO, Brayden DJ. Buccal delivery of small molecules and biologics: of mucoadhesive polymers, films, and nanoparticles. Curr Opin Pharmacol. 2017;36:22–28.
   PubMed Web of Science ®Google Scholar
• Mašek J, Lubasová D, Lukáč R, et al. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles - important step towards effective mucosal vaccines. J Control Release. 2017;249:183–195.
   PubMed Web of Science ®Google Scholar
• GuhaSarkar S, Banerjee R. Intravesical drug delivery: challenges, current status, opportunities and novel strategies. J Control Release. 2010;148(2):147–159.
   PubMed Web of Science ®Google Scholar
• Kolawole OM, Lau WM, Khutoryanskiy VV. Synthesis and evaluation of boronated chitosan as a mucoadhesive polymer for intravesical drug delivery. J Pharm Sci. 2019;108(9):3046–3053.
   PubMed Web of Science ®Google Scholar
• Rieger C, Kunhardt D, Kaufmann A, et al. Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer. Int J Pharm. 2015;479(2):357–363.
   PubMedGoogle Scholar
• Sahatsapan N, Ngawhirunpat T, Rojanarata T, et al. Catechol-functionalized alginate nanoparticles as mucoadhesive carriers for intravesical chemotherapy. AAPS PharmSciTech. 2020;21(6):212.
   PubMed Web of Science ®Google Scholar
• Barthelmes J, Dünnhaupt S, Unterhofer S, et al. Thiolated particles as effective intravesical drug delivery systems for treatment of bladder-related diseases. Nanomedicine (Lond). 2013;8(1):65–75.
   PubMed Web of Science ®Google Scholar
• Kong N, Zhang R, Wu G, et al. Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer. Proc Natl Acad Sci U S A. 2022;119:7.
   Web of Science ®Google Scholar
• Kumar R, Islam T, Nurunnabi M. Mucoadhesive carriers for oral drug delivery. J Control Release. 2022;351:504–559.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Chen R, Arafin S, et al. Intestinal iontophoresis from mucoadhesive patches: a strategy for oral delivery. J Control Release. 2019;297:71–78.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Krauland AH, Leitner VM, et al. Thiomers: potential excipients for non-invasive peptide delivery systems. Eur J Pharm Biopharm. 2004;58(2):253–263.
   PubMed Web of Science ®Google Scholar
• Lehr CM. Lectin-mediated drug delivery: the second generation of bioadhesives. J Control Release. 2000;65(1–2):19–29.
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Gokarn Y, Mitragotri S. Non-invasive delivery strategies for biologics. Nat Rev Drug Discov. 2019;18(1):19–40.
   PubMed Web of Science ®Google Scholar
• Chung SW, Hil-lal TA, Byun Y. Strategies for non-invasive delivery of biologics. J Drug Target. 2012;20(6):481–501.
   PubMed Web of Science ®Google Scholar
• Montenegro-Nicolini M, Morales JO. Overview and future potential of buccal mucoadhesive films as drug delivery systems for biologics. AAPS PharmSciTech. 2017;18(1):3–14.
   PubMed Web of Science ®Google Scholar
• de Barros JMS, Scherer T, Charalampopoulos D, et al. A laminated polymer film formulation for enteric delivery of live vaccine and probiotic bacteria. J Pharm Sci. 2014;103(7):2022–2032.
   PubMed Web of Science ®Google Scholar
• Mishra N, Goyal AK, Tiwari S, et al. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers. Expert Opin Ther Pat. 2010;20(5):661–679.
   PubMed Web of Science ®Google Scholar
• Li T, Bao Q, Shen J, et al. Mucoadhesive in situ forming gel for oral mucositis pain control. Int J Pharm. 2020;580:119238.
   PubMedGoogle Scholar
• Efiana NA, Mahmood A, Lam HT, et al. Improved mucoadhesive properties of self-nanoemulsifying drug delivery systems (SNEDDS) by introducing acyl chitosan. Int J Pharm. 2017;519(1):206–212.
   PubMedGoogle Scholar
• Peng K, Shi Y, LaBarbiera A, et al. Mucoadhesive ionic liquid gel patches for oral delivery. ACS Biomater Sci Eng. 2020;6:5980–6459.
   PubMedGoogle Scholar
• (WHO) WHO. WHO Coronavirus (Covid 19)2022 [ cited 21 December 2022]. https://covid19.who.int/
   Google Scholar
• Prasher P, Sharma M. Mucoadhesive nanoformulations and their potential for combating COVID-19. Nanomedicine. 2021;16(28):2497–2501.
   PubMed Web of Science ®Google Scholar
• Thakur V, Ratho RK, Panda JJ. Respiratory delivery of favipiravir-tocilizumab combination through mucoadhesive protein-lipidic nanovesicles: prospective therapeutics against COVID-19. VirusDisease. 2021;32(1):131–136.
   PubMedGoogle Scholar
• Hock N, Racaniello GF, Aspinall S, et al. Thiolated nanoparticles for biomedical applications: mimicking the workhorses of our body. Adv Sci. 2022;9(1):2102451.
   Web of Science ®Google Scholar
• Heinemann L. The failure of exubera: are we beating a dead horse? J Diabetes Sci Technol. 2008;2(3):518–529.
   PubMedGoogle Scholar